1. Home
  2. WTI vs HRTX Comparison

WTI vs HRTX Comparison

Compare WTI & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo W&T Offshore Inc.

WTI

W&T Offshore Inc.

N/A

Current Price

$3.10

Market Cap

309.5M

Sector

Energy

ML Signal

N/A

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

N/A

Current Price

$1.00

Market Cap

265.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WTI
HRTX
Founded
1983
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
309.5M
265.9M
IPO Year
2004
2007

Fundamental Metrics

Financial Performance
Metric
WTI
HRTX
Price
$3.10
$1.00
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
4.7M
1.8M
Earning Date
01-01-0001
05-28-2026
Dividend Yield
1.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$487,096,000.00
$154,904,000.00
Revenue This Year
N/A
$15.28
Revenue Next Year
N/A
$20.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.36
52 Week Low
$1.09
$0.95
52 Week High
$3.48
$2.61

Technical Indicators

Market Signals
Indicator
WTI
HRTX
Relative Strength Index (RSI) 65.82 31.77
Support Level $1.67 N/A
Resistance Level N/A $1.36
Average True Range (ATR) 0.28 0.09
MACD 0.03 -0.02
Stochastic Oscillator 53.48 12.97

Price Performance

Historical Comparison
WTI
HRTX

About WTI W&T Offshore Inc.

W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: